Finally, overexpression of both B7 proteins on AML cells is linked to poor prognosis [75,79], and blocking of CTLA-4/B7 interaction seems to be a promising strategy for therapy of myeloid leukemias. Here, CTLA4 is linked to myeloid leukemia.